Cargando…
NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma
SIMPLE SUMMARY: It is a long-held notion that loss-of-function mutations in negative regulators of the Hippo-YAP pathway, such as NF2, LATS1/2, have a similar potential to promote nuclear YAP activity, which is thought to play an essential role in the pathogenesis of MPM. Whether loss-of-function in...
Autores principales: | Yang, Haitang, Hall, Sean R. R., Sun, Beibei, Zhao, Liang, Gao, Yanyun, Schmid, Ralph A., Tan, Swee T., Peng, Ren-Wang, Yao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036327/ https://www.ncbi.nlm.nih.gov/pubmed/33805359 http://dx.doi.org/10.3390/cancers13071561 |
Ejemplares similares
-
Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma
por: Yang, Haitang, et al.
Publicado: (2020) -
Targeting YAP in malignant pleural mesothelioma
por: Zhang, Wen‐Qian, et al.
Publicado: (2017) -
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma
por: Xu, Duo, et al.
Publicado: (2019) -
Therapeutic Landscape of Malignant Pleural Mesothelioma: Collateral Vulnerabilities and Evolutionary Dependencies in the Spotlight
por: Xu, Duo, et al.
Publicado: (2020) -
Hippo-Independent Regulation of Yki/Yap/Taz: A Non-canonical View
por: Cho, Yong Suk, et al.
Publicado: (2021)